annual FCF:
$475.42M+$423.77M(+820.51%)Summary
- As of today (September 13, 2025), BMRN annual free cash flow is $475.42 million, with the most recent change of +$423.77 million (+820.51%) on December 31, 2024.
- During the last 3 years, BMRN annual FCF has risen by +$290.11 million (+156.55%).
- BMRN annual FCF is now at all-time high.
Performance
BMRN Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$167.90M+$10.28M(+6.52%)Summary
- As of today (September 13, 2025), BMRN quarterly free cash flow is $167.90 million, with the most recent change of +$10.28 million (+6.52%) on June 30, 2025.
- Over the past year, BMRN quarterly FCF has increased by +$70.98 million (+73.23%).
- BMRN quarterly FCF is now -16.18% below its all-time high of $200.31 million, reached on September 30, 2024.
Performance
BMRN quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$691.16M+$70.98M(+11.45%)Summary
- As of today (September 13, 2025), BMRN TTM free cash flow is $691.16 million, with the most recent change of +$70.98 million (+11.45%) on June 30, 2025.
- Over the past year, BMRN TTM FCF has increased by +$478.36 million (+224.79%).
- BMRN TTM FCF is now at all-time high.
Performance
BMRN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
BMRN Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +820.5% | +73.2% | +224.8% |
| 3 y3 years | +156.6% | +495.6% | +10000.0% |
| 5 y5 years | +512.9% | +3021.1% | +2198.8% |
BMRN Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +971.7% | -16.2% | +270.1% | at high | >+9999.0% |
| 5 y | 5-year | at high | +512.9% | -16.2% | +270.1% | at high | +1425.2% |
| alltime | all time | at high | +205.8% | -16.2% | +177.5% | at high | +236.2% |
BMRN Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $167.90M(+6.5%) | $691.16M(+11.4%) |
| Mar 2025 | - | $157.63M(-4.7%) | $620.18M(+30.4%) |
| Dec 2024 | $475.42M(+820.5%) | $165.33M(-17.5%) | $475.42M(+58.0%) |
| Sep 2024 | - | $200.31M(+106.7%) | $300.88M(+41.4%) |
| Jun 2024 | - | $96.92M(+653.3%) | $212.80M(+30.4%) |
| Mar 2024 | - | $12.87M(-239.7%) | $163.21M(+216.0%) |
| Dec 2023 | $51.65M(+16.4%) | -$9.21M(-108.2%) | $51.65M(+65.1%) |
| Sep 2023 | - | $112.23M(+137.1%) | $31.29M(-23.5%) |
| Jun 2023 | - | $47.33M(-148.0%) | $40.91M(+87.9%) |
| Mar 2023 | - | -$98.70M(+233.7%) | $21.77M(-50.9%) |
| Dec 2022 | $44.36M(-76.1%) | -$29.57M(-124.3%) | $44.36M(+8.8%) |
| Sep 2022 | - | $121.85M(+332.2%) | $40.76M(-1027.5%) |
| Jun 2022 | - | $28.19M(-137.0%) | -$4.39M(-118.3%) |
| Mar 2022 | - | -$76.11M(+129.4%) | $23.95M(-87.1%) |
| Dec 2021 | $185.31M(-455.3%) | -$33.18M(-143.3%) | $185.31M(+12.1%) |
| Sep 2021 | - | $76.70M(+35.7%) | $165.24M(+6.9%) |
| Jun 2021 | - | $56.53M(-33.7%) | $154.59M(+67.5%) |
| Mar 2021 | - | $85.26M(-260.1%) | $92.31M(-277.0%) |
| Dec 2020 | -$52.15M(-54.7%) | -$53.25M(-180.6%) | -$52.15M(+2068.6%) |
| Sep 2020 | - | $66.05M(-1249.1%) | -$2.40M(-92.7%) |
| Jun 2020 | - | -$5.75M(-90.3%) | -$32.93M(-60.9%) |
| Mar 2020 | - | -$59.21M(+1592.2%) | -$84.15M(-22.5%) |
| Dec 2019 | -$115.14M(-7.4%) | -$3.50M(-109.8%) | -$108.57M(+11.0%) |
| Sep 2019 | - | $35.53M(-162.4%) | -$97.77M(-28.1%) |
| Jun 2019 | - | -$56.97M(-31.9%) | -$135.96M(+0.4%) |
| Mar 2019 | - | -$83.62M(-1246.3%) | -$135.36M(+8.8%) |
| Dec 2018 | -$124.41M(-40.2%) | $7.29M(-374.4%) | -$124.41M(-20.7%) |
| Sep 2018 | - | -$2.66M(-95.3%) | -$156.98M(-1.0%) |
| Jun 2018 | - | -$56.38M(-22.4%) | -$158.51M(+20.9%) |
| Mar 2018 | - | -$72.67M(+187.5%) | -$131.12M(-37.0%) |
| Dec 2017 | -$207.98M(-44.7%) | -$25.28M(+503.2%) | -$207.98M(-11.3%) |
| Sep 2017 | - | -$4.19M(-85.5%) | -$234.48M(-12.1%) |
| Jun 2017 | - | -$28.98M(-80.6%) | -$266.76M(-13.7%) |
| Mar 2017 | - | -$149.53M(+188.8%) | -$309.09M(-17.8%) |
| Dec 2016 | -$376.22M(-16.3%) | -$51.78M(+42.0%) | -$376.22M(-24.2%) |
| Sep 2016 | - | -$36.46M(-48.9%) | -$496.44M(-2.2%) |
| Jun 2016 | - | -$71.31M(-67.1%) | -$507.38M(+4.8%) |
| Mar 2016 | - | -$216.66M(+26.0%) | -$484.36M(+7.8%) |
| Dec 2015 | -$449.50M(+132.8%) | -$172.01M(+262.8%) | -$449.50M(+34.8%) |
| Sep 2015 | - | -$47.41M(-1.8%) | -$333.48M(+4.2%) |
| Jun 2015 | - | -$48.28M(-73.4%) | -$320.02M(-1.2%) |
| Mar 2015 | - | -$181.81M(+224.8%) | -$323.80M(+67.7%) |
| Dec 2014 | -$193.05M(+54.7%) | -$55.98M(+64.9%) | -$193.05M(+8.4%) |
| Sep 2014 | - | -$33.95M(-34.8%) | -$178.04M(+6.7%) |
| Jun 2014 | - | -$52.06M(+2.0%) | -$166.79M(+26.4%) |
| Mar 2014 | - | -$51.05M(+24.6%) | -$131.95M(+5.8%) |
| Dec 2013 | -$124.76M(+362.7%) | -$40.98M(+80.6%) | -$124.76M(+45.6%) |
| Sep 2013 | - | -$22.69M(+31.7%) | -$85.69M(+34.3%) |
| Jun 2013 | - | -$17.23M(-60.7%) | -$63.79M(+11.0%) |
| Mar 2013 | - | -$43.85M(+2197.3%) | -$57.47M(+113.1%) |
| Dec 2012 | -$26.96M(-80.1%) | -$1.91M(+138.9%) | -$26.96M(-76.5%) |
| Sep 2012 | - | -$799.00K(-92.7%) | -$114.91M(-28.9%) |
| Jun 2012 | - | -$10.90M(-18.3%) | -$161.64M(+16.2%) |
| Mar 2012 | - | -$13.35M(-85.1%) | -$139.08M(+2.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$135.47M(+341.0%) | -$89.86M(+89.1%) | -$135.47M(+87.8%) |
| Sep 2011 | - | -$47.53M(-507.7%) | -$72.13M(+189.4%) |
| Jun 2011 | - | $11.66M(-219.7%) | -$24.92M(-15.8%) |
| Mar 2011 | - | -$9.74M(-63.3%) | -$29.60M(-3.6%) |
| Dec 2010 | -$30.71M(+1384.5%) | -$26.52M(+8320.0%) | -$30.71M(+318.1%) |
| Sep 2010 | - | -$315.00K(-104.5%) | -$7.35M(+62.7%) |
| Jun 2010 | - | $6.98M(-164.3%) | -$4.52M(-68.2%) |
| Mar 2010 | - | -$10.86M(+244.2%) | -$14.21M(+586.8%) |
| Dec 2009 | -$2.07M(-96.8%) | -$3.15M(-225.4%) | -$2.07M(-69.9%) |
| Sep 2009 | - | $2.52M(-192.7%) | -$6.87M(-65.0%) |
| Jun 2009 | - | -$2.71M(-311.4%) | -$19.61M(-11.5%) |
| Mar 2009 | - | $1.28M(-116.1%) | -$22.15M(-66.2%) |
| Dec 2008 | -$65.54M(+15.2%) | -$7.96M(-22.2%) | -$65.54M(+0.1%) |
| Sep 2008 | - | -$10.23M(+94.8%) | -$65.46M(-7.3%) |
| Jun 2008 | - | -$5.25M(-87.5%) | -$70.61M(-6.7%) |
| Mar 2008 | - | -$42.11M(+434.9%) | -$75.66M(+32.9%) |
| Dec 2007 | -$56.91M(-23.8%) | -$7.87M(-48.8%) | -$56.91M(-9.6%) |
| Sep 2007 | - | -$15.38M(+49.4%) | -$62.98M(+0.6%) |
| Jun 2007 | - | -$10.29M(-55.9%) | -$62.62M(-19.5%) |
| Mar 2007 | - | -$23.36M(+67.5%) | -$77.79M(+4.2%) |
| Dec 2006 | -$74.67M(+13.8%) | -$13.95M(-7.1%) | -$74.67M(-7.6%) |
| Sep 2006 | - | -$15.02M(-41.0%) | -$80.81M(-8.6%) |
| Jun 2006 | - | -$25.46M(+25.8%) | -$88.39M(+32.1%) |
| Mar 2006 | - | -$20.24M(+0.8%) | -$66.90M(+1.9%) |
| Dec 2005 | -$65.64M(-26.4%) | -$20.08M(-11.1%) | -$65.64M(+4.7%) |
| Sep 2005 | - | -$22.59M(+468.1%) | -$62.70M(-11.6%) |
| Jun 2005 | - | -$3.98M(-79.1%) | -$70.93M(-23.7%) |
| Mar 2005 | - | -$18.98M(+10.8%) | -$92.94M(+4.2%) |
| Dec 2004 | -$89.22M(+10.5%) | -$17.14M(-44.4%) | -$89.22M(-17.7%) |
| Sep 2004 | - | -$30.83M(+18.7%) | -$108.40M(+6.2%) |
| Jun 2004 | - | -$25.98M(+70.2%) | -$102.08M(+21.4%) |
| Mar 2004 | - | -$15.26M(-58.0%) | -$84.07M(+4.1%) |
| Dec 2003 | -$80.77M(+38.2%) | -$36.32M(+48.2%) | -$80.77M(+2.1%) |
| Sep 2003 | - | -$24.50M(+207.1%) | -$79.12M(+29.1%) |
| Jun 2003 | - | -$7.98M(-33.3%) | -$61.30M(+2.4%) |
| Mar 2003 | - | -$11.97M(-65.5%) | -$59.84M(+2.4%) |
| Dec 2002 | -$58.46M(+43.0%) | -$34.67M(+419.1%) | -$58.46M(+60.8%) |
| Sep 2002 | - | -$6.68M(+2.4%) | -$36.36M(-13.9%) |
| Jun 2002 | - | -$6.53M(-38.3%) | -$42.24M(+0.9%) |
| Mar 2002 | - | -$10.58M(-15.9%) | -$41.87M(+2.4%) |
| Dec 2001 | -$40.88M(+145.4%) | -$12.57M(+0.1%) | -$40.88M(+24.0%) |
| Sep 2001 | - | -$12.56M(+104.1%) | -$32.97M(+44.9%) |
| Jun 2001 | - | -$6.16M(-35.8%) | -$22.76M(+15.0%) |
| Mar 2001 | - | -$9.58M(+105.4%) | -$19.79M(+18.8%) |
| Dec 2000 | -$16.66M(-55.4%) | -$4.67M(+98.5%) | -$16.66M(-12.6%) |
| Sep 2000 | - | -$2.35M(-26.2%) | -$19.05M(-37.8%) |
| Jun 2000 | - | -$3.19M(-50.6%) | -$30.62M(-13.7%) |
| Mar 2000 | - | -$6.45M(-8.6%) | -$35.46M(-1.2%) |
| Dec 1999 | -$37.38M(+158.8%) | -$7.06M(-49.3%) | -$35.88M(+24.5%) |
| Sep 1999 | - | -$13.92M(+73.3%) | -$28.82M(+93.4%) |
| Jun 1999 | - | -$8.03M(+16.8%) | -$14.91M(+116.8%) |
| Mar 1999 | - | -$6.88M | -$6.88M |
| Dec 1998 | -$14.44M(+346.2%) | - | - |
| Dec 1997 | -$3.24M | - | - |
FAQ
- What is BioMarin Pharmaceutical Inc. annual free cash flow?
- What is the all time high annual FCF for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. annual FCF year-on-year change?
- What is BioMarin Pharmaceutical Inc. quarterly free cash flow?
- What is the all time high quarterly FCF for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. quarterly FCF year-on-year change?
- What is BioMarin Pharmaceutical Inc. TTM free cash flow?
- What is the all time high TTM FCF for BioMarin Pharmaceutical Inc.?
- What is BioMarin Pharmaceutical Inc. TTM FCF year-on-year change?
What is BioMarin Pharmaceutical Inc. annual free cash flow?
The current annual FCF of BMRN is $475.42M
What is the all time high annual FCF for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high annual free cash flow is $475.42M
What is BioMarin Pharmaceutical Inc. annual FCF year-on-year change?
Over the past year, BMRN annual free cash flow has changed by +$423.77M (+820.51%)
What is BioMarin Pharmaceutical Inc. quarterly free cash flow?
The current quarterly FCF of BMRN is $167.90M
What is the all time high quarterly FCF for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high quarterly free cash flow is $200.31M
What is BioMarin Pharmaceutical Inc. quarterly FCF year-on-year change?
Over the past year, BMRN quarterly free cash flow has changed by +$70.98M (+73.23%)
What is BioMarin Pharmaceutical Inc. TTM free cash flow?
The current TTM FCF of BMRN is $691.16M
What is the all time high TTM FCF for BioMarin Pharmaceutical Inc.?
BioMarin Pharmaceutical Inc. all-time high TTM free cash flow is $691.16M
What is BioMarin Pharmaceutical Inc. TTM FCF year-on-year change?
Over the past year, BMRN TTM free cash flow has changed by +$478.36M (+224.79%)